Identification of target genes of SMAD4 signaling network inhibit pancreatic tumor metastasis and chemoresistance
碩士 === 國立中山大學 === 生物醫學研究所 === 98 === Pancreatic ductal adenocarcinoma (PDAC) is one of the most insidious forms of cancer whose incidence nearly equals its death rate. Despite extensive research studies, no effective therapeutic approaches for diminishing the morbidity associated with this disease a...
Main Authors: | Sz-yang Huang, 黃斯暘 |
---|---|
Other Authors: | Kuang-Hung Cheng |
Format: | Others |
Language: | en_US |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/36060792436590352233 |
Similar Items
-
Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance
by: Ntombikayise Xelwa, et al.
Published: (2021-06-01) -
HEATR1 Deficiency Promotes Chemoresistance via Upregulating ZNF185 and Downregulating SMAD4 in Pancreatic Cancer
by: Yuan Fang, et al.
Published: (2020-01-01) -
Metformin inhibits pancreatic cancer metastasis caused by SMAD4 deficiency and consequent HNF4G upregulation
by: Chengcheng Wang, et al.
Published: (2020-07-01) -
Inhibition of tumor invasion and metastasis by targeting TGF-β-Smad-MMP2 pathway with Asiatic acid and Naringenin
by: Guang-Yu Lian, et al.
Published: (2021-03-01) -
CXCR4/Let-7a Axis Regulates Metastasis and Chemoresistance of Pancreatic Cancer Cells Through Targeting HMGA2
by: Guangfa Xiao, et al.
Published: (2017-09-01)